Olea Medical and Median Technologies to bring AI lung cancer screening software to the US market

Aug 3, 2026 · Issue 1 · 2 sources, 2 articles

Canon Medical Systems' Olea Medical is expanding U.S. access to eyonis LCS, its AI-powered lung cancer screening software. Median Technologies is collaborating with Olea Medical to commercialize the software.

Who is affected and how

medtech company

Distribution partnerships between imaging vendors and AI software makers can speed market entry.

Sources

• Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening Intradopr.chinookobserver.com · Aug 3, 2026
• Median Technologies collaborates with Olea Medical to commercialize AI lung cancer software | HealthCare Middle East & Africa - No.1 Health & Pharma Manufacturing Industry Publicationhealthcaremea.com · Aug 3, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.